Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efalizumab Monotherapy vs Combination with Topical Corticosteroids in Psoriasis
NCT00096980Phase 4Completed
- Sponsor
- Genentech
- Start
- Feb 2001
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
01
Overview
A Phase 4 trial of efalizumab in plaque psoriasis, sponsored by Genentech. Started Feb 2001; status: completed.
02
Drugs
efalizumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00096980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00096980.